MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

From Medicineworld.org: Women and colonoscopy screening

Colon cancer main Colon cancer basics Treatment of colon cancer  

Women and colonoscopy screening


This study was comprised of 10,164 patients from the PLCO screening trial who had a negative/normal initial screen. These patients were scheduled for repeat flexible sigmoidoscopy three years after the initial screening. Almost 87 percent of eligible patients returned for repeat screening.

Measures of nonadherence with repeat sigmoidoscopy varied significantly according to gender. Compared with men, women missed the year-three clinic almost two times more often than men, and women who attended the year-three clinic refused repeat sigmoidoscopy more than two times more often than men.

Reference: Weissfeld JL, Ling BS, et al. "Adherence to Repeat Screening Flexible Sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial." Cancer. Vol. 94, 2002.


Cancer terms:
Alopecia: Loss of hair. When the doctor says this chemotherapy has less chance of alopecia it means that that particular chemotherapy drug has lower chance of causing hair loss.

Medicineworld.org: Women and colonoscopy screening

Adjuvant therapy| Colon cancer aasics| Colon cancer staging| Colon cancer support| Books| Diagnosis| Epidemiology| Genetic risk factors| Colon Cancer Main| Neoadjuvant| Risk factors| Statistics| Surgical treatment| Non metastatic| Causes| What is| Bevacizumab plus IFL| Colon cancer news| Oxaliplatin plus avastin| Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news| Pancreatic cancer news| Prostate cancer news| Endometrial cancer news| General info| What is cancer?| Cancer causes| Is cancer hereditary?| Types of cancer| Cancer statistics|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.